Diagnosing hepatocellular carcinoma: A virtual reality
Richard B. Freeman – 30 December 2003
Donor and recipient outcomes in right lobe adult living donor liver transplantation
Rafik M. Ghobrial, Sammy Saab, Charles Lassman, David S.K. Lu, Steven Raman, Piyagorn Limanond, Greg Kunder, Karyn Marks, Farin Amersi, Dean Anselmo, Pauline Chen, Douglas Farmer, Steven Han, Francisco Durazo, Leonard I. Goldstein, Ronald W. Busuttil – 30 December 2003 – Severe donor organ shortage has provided the impetus for adult living donor liver transplantation (ALDLT). Despite rapid implementation and expansion of the procedure, outcome analysis of ALDLT is still incomplete. This study analyzed both donor and recipient outcomes after ALDLT at a single center.
Induction immunosuppression in hepatitis C virus–infected liver transplant recipients
Michael R. Lucey – 30 December 2003
Socioeconomic status does not affect the outcome of liver transplantation
Hwan Y. Yoo, Violetta Galabova, David Edwin, Paul J. Thuluvath – 30 December 2003 – The outcome of liver transplantation is dependent on many factors. It was suggested that racial disparities in outcome may be related to differences in socioeconomic status (SES). In this retrospective study, we analyzed the effect of SES on graft and patient survival. Two hundred seventy‐six adult patients who underwent liver transplantation at our institution from July 1988 to June 2001 were included in the analysis.
Metastatic leiomyosarcoma mimicking polycystic liver disease
Kimberly L. Beavers, Michael W. Fried, Mark W. Johnson, Steven L. Zacks, David A. Gerber, Jeffrey H. Fair, Kenneth A. Andreoni, Pat Odell, Roshan Shrestha – 30 December 2003
Atypical abdominal pain in a liver transplant recipient
Alexander E. Handschin, Zakiyah Kadry, Markus Selzner, Beat Müllhaupt, Eberhard Renner, Markus Weber, Pierre‐Alain Clavien – 30 December 2003
Hepatocellular carcinoma: Gardening strategies and bridges to transplantation
Gregory J. Gores – 30 December 2003 – Background: Survival after liver transplantation for early hepatocellular carcinoma (HCC) is worsened by the increasing dropout rate while waiting for a donor.
Mediastinal recurrence of alveolar echinococcosis after liver transplantation
François Mosimann, Vincent Bettschart, Reto Meuli – 30 December 2003
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency
Hans L. Tillmann, C. Thomas Bock, Jörg S. Bleck, Jens Rosenau, Klaus H. W. Böker, Hannelore Barg‐Hock, Thomas Becker, Christian Trautwein, Jürgen Klempnauer, Peer Flemming, Michael P. Manns – 30 December 2003 – Fibrosing cholestatic hepatitis is a deleterious manifestation of hepatitis B virus infection in immunocompromised patients. Without treatment, this condition is usually fatal within weeks of onset. Liver retransplantation has not been successfully performed to date, and treatment intervention was generally unsuccessful before the advent of adefovir dipivoxil.